Early premorbid adjustment as a moderator of the impact of duration of untreated psychosis

Schizophrenia Research

Volumn 95, Issue 1-3, 2007, Pages 111-114

  Norman, Ross M G ^a   Malla, Ashok K ^b   Manchanda, Rahul ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Duration of untreated psychosis; Premorbid adjustment; Treatment outcome

Indexed keywords

ARTICLE; CHILDHOOD; INFORMATION PROCESSING; MORBIDITY; PRIORITY JOURNAL; PSYCHOSIS; SYMPTOMATOLOGY;

ACHIEVEMENT; ADAPTATION, PSYCHOLOGICAL; ADULT; ANTIPSYCHOTIC AGENTS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548179518     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.06.007     Document Type: Article

References (15)

1. Aguinis H. Regression Analysis for Categorical Moderators (2004), Guildford Press, New York
2. Andreasen N.C. The Scale for the Assessment of Negative Symptoms (SANS) (1983), University of Iowa, Iowa City
3. Andreasen N.C. The Scale for the Assessment of Positive symptoms (SAPS) (1984), University of Iowa, Iowa City
4. Cannon-Spoor H.E., Potkin S.G., and Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr. Bull. 8 (1982) 470-484
5. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. Structured Clinical Interview of DSM-IV Axis I (SCIDI). Clinical Version, Biometrics Research Department (1995), New York State Psychiatric Institute
6. Haas G.L., and Sweeney J.A. Premorbid and onset features of first-episode schizophrenia. Schizophr. Bull. 18 (1992) 373-386
7. Malla P.K., Norman R.M.G., McLean T.S., and Scholten D. A Canadian programme for early intervention in non-affective psychotic disorders. Aust. N.Z J. Psychiatry 37 (2003) 407-413
8. Marshall M., Lewis S., Lockwood A., Drake R., Jones P., and Coudace T. Association between duration of untreated psychosis and outcomes in cohorts of first episode patients. Arch. Gen. Psychiatry 62 (2005) 975-983
9. McCabe J.H., Aldovri E., Fahy T.A., Sham P.C., and Murray R.M. Do schizophrenic patients who managed to get to university have a non-developmental form of illness?. Psychol. Med. 32 (2002) 535-544
10. McGlashan T.H. Schizophrenia in translation: is active psychosis neurotoxic?. Schizophr. Bull. 32 (2006) 609-613
11. Murray R.M., O'Callaghan E., Castle D.J., and Lewis S.W. A neurodevelopmental approach to the classification of schizophrenia. Schizophr. Bull. 18 (1992) 319-332
12. Norman R.M.G., and Malla A.K. Duration of untreated psychosis: a critical evaluation of the concept and its importance. Psychol. Med. 31 (2001) 381-400
13. Strous R.D., Alvir J., Ma J., Dobinson D., Gal G., Sheitman B., Chakos M., and Lieberman J.A. Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects. Schizophr. Bull. 30 (2004) 265-278
14. Van Os J., Jones P., Sharma P., Bebbington P., and Murray R.M. Risk factors for onset and persistence of psychosis. Soc. Psychiatry Psychiatr. Epidemiol. 33 (1998) 596-605
15. Wyatt R.J. Neuroleptics and the natural course of schizophrenia. Schizophr. Bull. 17 (1991) 325-359